- $185.57m
- $140.05m
- $31.79m
- 81
- 25
- 92
- 72
Annual balance sheet for Brainsway, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 21.7 | 17 | 16.9 | 47.6 | 46 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6.26 | 6.44 | 6.92 | 5.45 | 4.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 28.8 | 24.3 | 65.4 | 58.1 | 55.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 9.74 | 9.55 | 9.33 | 5.35 | 5.79 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 38.7 | 34 | 75.7 | 64.5 | 63 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.72 | 6.8 | 9.07 | 8.14 | 9.76 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 14.5 | 14.4 | 18.4 | 19.1 | 21.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 24.2 | 19.6 | 57.3 | 45.4 | 41.6 |
| Total Liabilities & Shareholders' Equity | 38.7 | 34 | 75.7 | 64.5 | 63 |
| Total Common Shares Outstanding |